Submissions from 2024
Applications of nitric oxide-releasing nanomaterials in dermatology: Skin infections and wound healing, Sara Abdel Azim, Cleo Whiting, and Adam J. Friedman
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial, April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, and Kim Papp
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial, April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, and Kim Papp
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis, April W. Armstrong, H Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, and Jonathan I. Silverberg
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis, April W. Armstrong, H Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, and Jonathan I. Silverberg
Evaluating the Readability of the iPledge Comprehension Assessment and its Impact on Isotretinoin Accessibility, Peter Baek, Nidhi Shah, and A Yasmine Kirkorian
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial, Andrew Blauvelt, Zoe D. Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B. Forman, Melinda Gooderham, Lawrence Green, Scott T. Guenthner, Adelaide A. Hebert, Edward Lain, Angela Y. Moore, Kim A. Papp, Matthew Zirwas, Saori Kato, Scott Snyder, David Krupa, Patrick Burnett, David R. Berk, and David H. Chu
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis, Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, and Jonathan I. Silverberg
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis, Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, and Jonathan I. Silverberg
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial, Andrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H. De Oliveira, and Jonathan I. Silverberg
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial, Andrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H. De Oliveira, and Jonathan I. Silverberg
Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients, Heather A. Brandling-Bennett, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo-Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin M. Dalrymple, Carsten Flohr, Ken B. Gordon, Diane Hanna, Alan D. Irvine, Susan Kim, A Yasmine Kirkorian, Irene Lara-Corrales, Jill Lindstrom, Amy S. Paller, Melissa Reyes, Wendy Smith Begolka, Wynnis L. Tom, Abby S. Van Voorhees, Ruth Ann Vleugels, Lara Wine Lee, Olivia Davies, and Elaine C. Siegfried
Association of alopecia areata and ischemic heart disease and cerebrovascular in U.S. adults: an all of us database study, Stella Caldas, Angel D. Pagan, Juliana Pulsinelli, Joel Correa da Rosa, Seungyeon Jung, Divija Sharma, Jonas A. Adalsteinsson, and Benjamin Ungar
Pediatric Cutaneous T-Cell Neoplasms: Clinical and Pathological Features, Updated Classifications, and Critical Differential Diagnoses, Jinjun Cheng, Birte Wistinghausen, and A Yasmine Kirkorian
Attitudes, practices, facilitators, and barriers to sexual orientation and gender identity data collection in dermatology practices, Richard Chen, Temi Adekunle, Lena Chu, Ronnie Festok, Julia L. Gao, Daniel A. Yanes, Erica D. Dommasch, John G. Zampella, and Howa Yeung
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC, Shayan Cheraghlou, Mary L. Stevenson, Sean R. Christensen, Jeremy S. Bordeaux, Joanna L. Walker, Divya Srivastava, Carla Ferrándiz-Pulido, Kristin P. Bibee, Joi B. Carter, Faramarz H. Samie, Vishal A. Patel, Bryan T. Carroll, Allison T. Vidimos, Christian L. Baum, Justin J. Leitenberger, Anokhi Jambusaria-Pahlajani, Emily S. Ruiz, John A. Carucci, David R. Carr, and Kathryn T. Shahwan
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC, Shayan Cheraghlou, Mary L. Stevenson, Sean R. Christensen, Jeremy S. Bordeaux, Joanna L. Walker, Divya Srivastava, Carla Ferrándiz-Pulido, Kristin P. Bibee, Joi B. Carter, Faramarz H. Samie, Vishal A. Patel, Bryan T. Carroll, Allison T. Vidimos, Christian L. Baum, Justin J. Leitenberger, Anokhi Jambusaria-Pahlajani, Emily S. Ruiz, John A. Carucci, David R. Carr, and Kathryn T. Shahwan
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K. Chu, Lynda Schneider, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Stephen A. Martin, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Kathryn E. Wheeler, and Gordon H. Guyatt
Photopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009-2020, Vincent A. DeLeo, Brandon L. Adler, Donald V. Belsito, Melanie D. Pratt, Denis Sasseville, Margo J. Reeder, Erin M. Warshaw, Amber R. Atwater, James S. Taylor, Frances Storrs, James G. Marks, Joel G. DeKoven, Jonathan Silverberg, JiaDe Yu, Nina Botto, Marie-Claude Houle, Christen M. Mowad, and Cory A. Dunnick
Isotretinoin for rosacea: A systematic review, Sapana Desai and Adam Friedman
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials, Carla Dias-Barbosa, Jonathan I. Silverberg, Sonja Ständer, Danielle Rodriguez, Fatoumata Fofana, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany, Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Josef Paris, Katrin Jack, Olivier Chambenoit, Ramkumar Subramanian, Jorge Puelles, Elly Stolk, Ben van Hout, and Jonathan I. Silverberg
Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis, Lawrence F. Eichenfield, Jonathan I. Silverberg, Adelaide A. Hebert, and Mark Boguniewicz
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies, Lawrence F. Eichenfield, Eric L. Simpson, Kim Papp, Jacek C. Szepietowski, Andrew Blauvelt, Leon Kircik, Jonathan I. Silverberg, Elaine C. Siegfried, Michael E. Kuligowski, May E. Venturanza, Howard Kallender, Haobo Ren, and Amy S. Paller
Rx -to- OTC switch increased access and lowered cost of topical adapalene, William Fix, Sapana Desai, Dillon Nussbaum, and Adam Friedman
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria, Adam Friedman, Shawn G. Kwatra, and Gil Yosipovitch
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria, Adam Friedman, Shawn G. Kwatra, and Gil Yosipovitch
Hailey-Hailey disease successfully treated with tralokinumab and literature review of successful treatment with dupilumab, Kareena S. Garg, Jonathan Silverberg, and Leonardo Tjahjono
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor), Melinda Gooderham, Ronald Vender, Jeffrey Crowley, H Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, and Lawrence Green
Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Papulopustular Rosacea in Elderly Patients: Post-hoc Analysis of Results from Two Randomized, Phase III, Vehicle-controlled Trials, Lawrence J. Green, Hilary Baldwin, Jeffrey Sugarman, Bill Andriopoulos, Ori Nov, Ofra Levy-Hacham, Neal Bhatia, and William P. Werschler
Response to Bass et al.'s "Significant discordance in DermTech test results when paired with histopathology: Caveat emptor.", Lawrence J. Green, Brook Brouha, and Neal Bhatia
Pediatric dermatologic emergencies, Juliana R. Gruver and A Yasmine Kirkorian
A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council, Carter Haag, Andrew Alexis, Valeria Aoki, Robert Bissonnette, Andrew Blauvelt, Raj Chovatiya, Michael J. Cork, Simon G. Danby, Lawrence Eichenfield, Kilian Eyerich, Melinda Gooderham, Emma Guttman-Yassky, Dirk-Jan Hijnen, Alan Irvine, Norito Katoh, Dedee F. Murrell, Yael A. Leshem, Adriane Levin, Ida Vittrup, Jill I. Olydam, Raquel L. Orfali, Amy Paller, Yael Renert-Yuval, David Rosmarin, Jonathan Silverberg, Jacob Thyssen, Sonja Ständer, Nick Stefanovic, Gail Todd, JiaDe Yu, and Eric Simpson
Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis, Stella P. Hartono, Sheena Chatrath, Ozge N. Aktas, Stephanie A. Kubala, Korey Capozza, Ian A. Myles, Jonathan I. Silverberg, and Alan Schwartz
Nonhealing vulvar ulcer associated with hyperkeratotic depigmented plaques, Shivani Jain, Sydney Rivera, Emily Murphy, and Melissa M. Mauskar
Nonhealing vulvar ulcer associated with hyperkeratotic depigmented plaques, Shivani Jain, Sydney Rivera, Emily Murphy, and Melissa M. Mauskar
Increased loss-of-function filaggrin gene mutation prevalence in atopic dermatitis patients across northern latitudes indicates genetic fitness: A systematic review and meta-analysis, Casper Milde Khatib, Amalie Wandel Klein-Petersen, Amalie Thorsti Rønnstad, Alexander Egeberg, Maria Oberländer Christensen, Jonathan Ian Silverberg, Simon Francis Thomsen, Alan David Irvine, and Jacob Pontoppidan Thyssen
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib, Shawn G. Kwatra, Marjolein De Bruin-Weller, Jonathan I. Silverberg, Peter Lio, Mette Deleuran, Handan Aydin, Brian M. Calimlim, Michael C. Lane, Yingyi Liu, Sarah Ofori, and Stephan Weidinger
Topical Nanoencapsulated Cannabidiol Cream as an Innovative Strategy Combatting Ultraviolet A-Induced Nuclear and Mitochondrial DNA Injury: A Pilot Randomized Clinical Study, Erika McCormick, Haowei Han, Sara Abdel Azim, Cleo Whiting, Nitish Bhamidipati, Alexi Kiss, Tatiana Efimova, Brian Berman, and Adam Friedman
Insights from a joint pediatric dermatology-gynecology vulvar clinic: A retrospective study, Nikita Menta, Dillon Nussbaum, Aneka Khilnani, Tazim Dowlut-McElroy, and Kaiane A. Habeshian
Atopic Dermatitis: A Disorder of both Adults and Children with Varying Longitudinal Course, Shanthi Narla and Jonathan I. Silverberg
Bed Bugs, Scott A. Norton and Richard J. Pollack
Bed Bugs, Scott A. Norton and Richard J. Pollack
Reducing disparities in the care of atopic dermatitis, Uchechi Nwaneri, Candrice Heath, Andrew Alexis, Adam Friedman, and Jonathan I. Silverberg
Association between body mass index and vitiligo distribution: An observational cohort study, Ross O'Hagan, Samir Kamat, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
An observational cohort study of body mass index in pediatric vitiligo, Ross O'Hagan, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
An observational cohort study of body mass index in pediatric vitiligo, Ross O'Hagan, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis, Amy S. Paller, Lawrence J. Green, Nanette Silverberg, Stephen Stripling, Martina Cartwright, Carolyn Enloe, Nick Wells, Elaine Kearney Kowalewski, and Tomoko Maeda-Chubachi
Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years, Amy S. Paller, Jonathan I. Silverberg, Mercedes E. Gonzalez, Lynda C. Schneider, Robert Sidbury, Zhen Chen, Ashish Bansal, Zhixiao Wang, and Randy Prescilla
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study, Amy S. Paller, Jonathan I. Silverberg, Eric L. Simpson, Michael J. Cork, Peter D. Arkwright, Zhen Chen, Ashish Bansal, Randy Prescilla, Zhixiao Wang, and Ainara R. Marco
Evaluating the Content and Quality of the Top 50 #Cosmeticdermatology Instagram Posts, Vincent A. Pecora, Erika T. McCormick, Alexis E. Carrington, and Pooja Sodha
Targeting sebaceous glands: a review of selective photothermolysis for Acne Vulgaris treatment, Anika Pulumati, Dana Jaalouk, Yanci A. Algarin, Eli Kasheri, Naiem T. Issa, and Keyvan Nouri
Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases Codes, Tasya Rakasiwi, Chenin Ryan, Amy Stein, Alan Vu, Morgan Dykman, Ipsit Shah, Catherine Reilly, Gabrielle Brokamp, Mia A. Mologousis, Bailey Komishke, Vincent Hou, Sheilagh Maguiness, A Yasmine Kirkorian, Harper Price, Elena B. Hawryluk, Esteban Fernandez Faith, Irene Lara-Corrales, Emily Gurnee, Kristen E. Holland, and Jillian F. Rork
Occupational Contact Dermatitis in Construction Workers: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001-2020, Margo J. Reeder, Alexander Idrogo-Lam, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Jonathan I. Silverberg, Brandon L. Adler, Amber R. Atwater, James S. Taylor, Marie-Claude Houle, Donald V. Belsito, Jiade Yu, Nina Botto, Christen M. Mowad, Cory A. Dunnick, Vincent A. DeLeo, and Melanie D. Pratt
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020, Margo J. Reeder, Aman Nihal, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Marie-Claude Houle, Brandon L. Adler, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina B. Botto, Chris M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020, Margo J. Reeder, Aman Nihal, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Marie-Claude Houle, Brandon L. Adler, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina B. Botto, Chris M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients, Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, David Rosmarin, Lawrence F. Eichenfield, Leslie Castelo-Soccio, Victor Huang, Seemal R. Desai, Samantha Walsh, Jonathan I. Silverberg, Amy S. Paller, Michele Rodrigues, Mark Weingarten, Shanthi Narla, Jackie Gardner, Michael Siegel, Sidra Ibad, and Nanette B. Silverberg
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients, Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, David Rosmarin, Lawrence F. Eichenfield, Leslie Castelo-Soccio, Victor Huang, Seemal R. Desai, Samantha Walsh, Jonathan I. Silverberg, Amy S. Paller, Michele Rodrigues, Mark Weingarten, Shanthi Narla, Jackie Gardner, Michael Siegel, Sidra Ibad, and Nanette B. Silverberg
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study, Amalie Thorsti Rønnstad, Mia-Louise Nielsen, Christoph Schlapbach, Emma Guttman-Yassky, Jonathan I. Silverberg, Simon Francis Thomsen, Jacob P. Thyssen, and Alexander Egeberg
Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making, Archana Samynathan and Jonathan I. Silverberg
A review of hair removal modalities in pediatric patients: Ethical and clinical considerations, Eric Sanfilippo, Leslie Castelo-Soccio, and Anna Yasmine Kirkorian
A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice, Maria C. Schneeweiss, Robert J. Glynn, Richard Wyss, Priyanka Anand, Yinzhu Jin, Joan Landon, Arash Mostaghimi, Joseph F. Merola, Jonathan I. Silverberg, David M. Rosmarin, Robert Sidbury, and Sebastian Schneeweiss
Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER-2), J I. Silverberg, M N. Mustapa, F Reid, A Lei, R Smith, R Moate, A Kelly, R Chen, M Gavala, E Jimenez, M G. Belvisi, M W. Sadiq, C Kell, and H C. Pandya
Validation of the Investigator Global Assessment of Chronic Hand Eczema (IGA-CHE): a new clinician reported outcome measure of CHE severity, Jonathan I. Silverberg, Tove Agner, Keith Baranowski, Ursula Plohberger, Henrik Thoning, Rob Arbuckle, Laura Grant, George Skingley, and Robert Bissonnette
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up), Jonathan I. Silverberg, Christopher G. Bunick, H Chih-Ho Hong, Pedro Mendes-Bastos, Linda Stein Gold, Antonio Costanzo, Nadia Ibrahim, Cristina Sancho, Xiaoqiang Wu, Yu Han, Gweneth Levy, Kathy Altman, Brian Calimlim, and Kilian Eyerich
Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry, Jonathan I. Silverberg, Angel Cronin, Eric A. Jones, Swapna S. Dave, Robert R. McLean, Jeffrey Greenberg, Bruce Strober, Thomas Bieber, Melinda Gooderham, Amy S. Paller, and Eric L. Simpson
Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis in Adults and Children Down to 2 Years of Age in the Pivotal Phase 3 ADORING Trials, Jonathan I. Silverberg, Lawrence F. Eichenfield, Adelaide A. Hebert, Eric L. Simpson, Linda Stein Gold, Robert Bissonnette, Kim A. Papp, John Browning, Pearl Kwong, Neil J. Korman, Philip M. Brown, David S. Rubenstein, Stephen C. Piscitelli, Matthew C. Somerville, Anna M. Tallman, and Leon Kircik
Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry, Jonathan I. Silverberg, Linda Stein Gold, Seemal Desai, Alexandra Golant, Douglas DiRuggiero, D Christian Fenske, Alvin Li, Zach Dawson, Yolanda Muñoz Maldonado, Kaylee Ho, Kayla Callahan, and Eric L. Simpson
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2), Jonathan I. Silverberg, Melinda J. Gooderham, Amy S. Paller, Mette Deleuran, Christopher G. Bunick, Linda F. Gold, DirkJan Hijnen, Brian M. Calimlim, Wan-Ju Lee, Henrique D. Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M. Platt, and Diamant Thaçi
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis, Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, Marius Rademaker, Daria Fomina, Jan Gutermuth, Jiyoung Ahn, Fernando Valenzuela, Mahreen Ameen, Martin Steinhoff, Mark G. Kirchhof, Peter Lio, and Andreas Wollenberg
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study, Jonathan I. Silverberg, Robert S. Kirsner, David J. Margolis, Michael Tharp, Daniela E. Myers, Karen Annis, Daniela Graham, Chuanbo Zang, Bonnie L. Vlahos, and Paul Sanders
Patch Testing With Nickel, Cobalt, and Chromium in Patients With Suspected Allergic Contact Dermatitis, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Joel G. DeKoven, Donald V. Belsito, Amber R. Atwater, James S. Taylor, Denis Sasseville, Margo J. Reeder, Marie-Claude Houle, Vincent A. DeLeo, Howard I. Maibach, Joseph F. Fowler, Kathryn A. Zug, Melanie D. Pratt, JiaDe Yu, Christen M. Mowad, Nina C. Botto, and Brandon L. Adler
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials, Jonathan I. Silverberg, David Rosmarin, Raj Chovatiya, Thomas Bieber, Stephen Schleicher, Lisa Beck, Melinda Gooderham, Sohail Chaudhry, Christie Fanton, Danni Yu, Joshua Levy, Yi Liu, Takahiro Miyazaki, Mary Tagliaferri, Carsten Schmitz, Ajay Nirula, Brian Kotzin, and Jonathan Zalevsky
Phosphorylated p38 MAP kinase expression by leucocytes is increased in allergic humans and associated with IgE responses, Jonathan I. Silverberg, Tamar A. Smith-Norowitz, Stephan Kohlhoff, and Rauno Joks
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001), Jonathan I. Silverberg, Bruce Strober, Brian Feinstein, Jinhua Xu, Emma Guttman-Yassky, Eric L. Simpson, Pauline Li, Malinda Longphre, Jing Song, Jiawang Guo, Jang Yun, Belinda Williams, Wubin Pan, Selwyn Ho, Raúl Collazo, and Zheng Wei
Abrocitinib may improve itch and quality of life in patients with itch-dominant atopic dermatitis, Jonathan I. Silverberg, Jacob P. Thyssen, Irina Lazariciu, Daniela E. Myers, Erman Güler, and Raj Chovatiya
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials, Jonathan I. Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J. Legat, Kim A. Papp, Linda Stein Gold, Jean-David Bouaziz, Andrew E. Pink, José Manuel Carrascosa, Barbara Rewerska, Jacek C. Szepietowski, Dorota Krasowska, Blanka Havlíčková, Monika Kalowska, Nina Magnolo, Sylvia Pauser, Navid Nami, Maxwell B. Sauder, Vipul Jain, Kamila Padlewska, Soo Yeon Cheong, Patricia Fleuranceau Morel, Liliana Ulianov, and Christophe Piketty
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials, Jonathan I. Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J. Legat, Kim A. Papp, Linda Stein Gold, Jean-David Bouaziz, Andrew E. Pink, José Manuel Carrascosa, Barbara Rewerska, Jacek C. Szepietowski, Dorota Krasowska, Blanka Havlíčková, Monika Kalowska, Nina Magnolo, Sylvia Pauser, Navid Nami, Maxwell B. Sauder, Vipul Jain, Kamila Padlewska, Soo Yeon Cheong, Patricia Fleuranceau Morel, Liliana Ulianov, and Christophe Piketty
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment, Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch, Peter Lio, Jose-Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline Pierce, Helena Agell, and Sonja Ständer
Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment, Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch, Peter Lio, Jose-Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline Pierce, Helena Agell, and Sonja Ständer
VINDICATE-P: A Mnemonic for the Many Comorbidities of Atopic Dermatitis, Nanette B. Silverberg, Mary F. Lee-Wong, and Jonathan I. Silverberg
Atopic Dermatitis: The Era of Excellence in Care, Nanette B. Silverberg and Jonathan I. Silverberg
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis, Eric L. Simpson, Marjolein de Bruin-Weller, H Chih-Ho Hong, Delphine Staumont-Sallé, Andrew Blauvelt, Kilian Eyerich, Melinda Gooderham, Mona Shahriari, Lotus Mallbris, Amber Reck Atwater, Maria Jose Rueda, Yuxin Ding, Zhuqing Liu, Helena Agell, and Jonathan I. Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2), Eric L. Simpson, Vimal H. Prajapati, Yael A. Leshem, Raj Chovatiya, Marjolein S. de Bruin-Weller, Sonja Ständer, Andrew E. Pink, Brian M. Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M. Platt, and Jonathan I. Silverberg
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure, Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A. Farooqui, Gary Chan, Justine Alderfer, William Romero, and Kanti Chittuluru
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure, Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A. Farooqui, Gary Chan, Justine Alderfer, William Romero, and Kanti Chittuluru
Dupilumab treatment improves signs, symptoms, quality of life and work productivity in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial, Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Ewa Sygula, Marie L. Schuttelaar, Eric Mortensen, Elizabeth Laws, Bolanle Akinlade, Naimish Patel, Jennifer Maloney, Heather Paleczny, Dimittri Delevry, Jing Xiao, Ariane Dubost-Brama, and Ashish Bansal
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial, Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Ewa Syguła, Marie L. Schuttelaar, Eric Mortensen, Elizabeth Laws, Bolanle Akinlade, Naimish Patel, Jennifer Maloney, Heather Paleczny, Dimittri Delevry, Jing Xiao, Ariane Dubost-Brama, and Ashish Bansal
A Pivotal Study on the Safety and Effectiveness of a Targeted Alkali Thermolysis Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating, Stacy Smith, Dee Anna Glaser, Lawerence J. Green, Micheal S. Kaminer, Erin Tims, and David M. Pariser
The big picture: Terminology in laser medicine, Pooja Sodha, Jordan V. Wang, Roy G. Geronemus, and Paul M. Friedman
The big picture: Terminology in laser medicine, Pooja Sodha, Jordan V. Wang, Roy G. Geronemus, and Paul M. Friedman
Landscape of social networking support groups for common dermatological conditions, Audrey Terrany, Bianca Sanabria, Bassem Rafiq, and Babar Rao
Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN, J P. Thyssen, J I. Silverberg, J Ruano, A Blauvelt, W Gubelin, E L. Simpson, S Weidinger, H Valdez, K K. Terry, P Biswas, E Güler, and C Feeney
Lack of association of atopic dermatitis severity and morphology with asthma onset and control, Savanna I. Vidal and Jonathan I. Silverberg
Cross-sectional study of phenotypical differences of atopic dermatitis in Asian vs. White patients in the United States, Vincent Wan and Jonathan I. Silverberg
Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020), Erin M. Warshaw, Malina Yamashita Peterson, Joel G. DeKoven, Brandon L. Adler, Melanie D. Pratt, Donald V. Belsito, Amber R. Atwater, Marie-Claude Houle, Cory A. Dunnick, Jiade Yu, James S. Taylor, Jonathan I. Silverberg, Margo J. Reeder, Vincent A. DeLeo, Christen Mowad, and Nina C. Botto
Association of chronic kidney disease with hidradenitis suppurativa: A retrospective study, Chapman Wei, Ahmad Mustafa, John Strange, Radu Grovu, Theodore Strange, Adam J. Friedman, Stefan Bradu, Amit Garg, and Suzanne E. El-Sayegh
The Skin Microbiome and its Significance for Dermatologists, Cleo Whiting, Sara Abdel Azim, and Adam Friedman
The Skin Microbiome and its Significance for Dermatologists, Cleo Whiting, Sara Abdel Azim, and Adam Friedman
A cross-sectional survey of clinical trials knowledge, participation, and perspectives in an underserved community of Washington, DC, Cleo Whiting, Deega Omar, Sarah Millan, Andeulazia Murdock, Sara Abdel Azim, and Adam Friedman